Table 1 Clinical characteristics of IBD patients and controls.

From: CircRNA_103765 acts as a proinflammatory factor via sponging miR-30 family in Crohn’s disease

Characteristic

CD (A/R)

UC (A/R)

HCs

Number of patients

60 (34/26)

60 (35/25)

40

Mean age (yr)

35.94 ± 10.35

40.33 ± 11.58

38.24 ± 10.85

Gender

Male

37

33

21

female

23

27

19

Range (years)

16–65

25–70

18–65

Disease duration (years)

7.2 ± 5.3

8.4 ± 6.3

 

Disease location: CD, n

L1

26

  

L2

13

  

L3

21

  

L4

0

  

Disease behavior: CD, n

B1

18

  

B2

33

  

B3

9

  

Disease location: UC, n

E1

 

25

 

E2

 

22

 

E3

 

13

 

CRP (mg/L)

77.06 (14.66–133.14)

47.73 (3.81–113.27)

 

TNF-α (pg/mL)

7.74 (3.75–14.68)

6.70 (3.39–11.98)

 

CDAI score

182.15 (121.50–300.66)

  

Mayo score

 

1.0 (3.0–5.0)

 
  1. The data are presented as the mean ± SD or medians (1/4–3/4 quarters). Patients with isolated upper disease (L4) were excluded. L1 terminal ileum, L2 colon, L3 ileocolon, B1 non-stricture and non-penetrating, B2 stricturing, B3 penetrating, E1 rectum, E2 left side, E3 extensive, CD Crohn’s disease, UC ulcerative colitis, HCs healthy controls, CRP C-reactive protein, TNF-α tumor necrosis factor α, CDAI CD Activity Index, A/R active/remission.
Back to article page